Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Erratum: Ultrafast Doublon Dynamics in Photoexcited 1T-TaS_{2} [Phys. Rev. Lett. 120, 166401 (2018)].

Ligges M, Avigo I, Golež D, Strand HUR, Beyazit Y, Hanff K, Diekmann F, Stojchevska L, Kalläne M, Zhou P, Rossnagel K, Eckstein M, Werner P, Bovensiepen U.

Phys Rev Lett. 2019 Apr 19;122(15):159901. doi: 10.1103/PhysRevLett.122.159901.

PMID:
31050496
2.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018121232. doi: 10.1681/ASN.2018121232. [Epub ahead of print]

PMID:
31040191
3.

Postinfectious Acute Glomerulonephritis in Renal Transplantation: An Emergent Aetiology of Renal Allograft Loss.

Molina-Andújar A, Montagud-Marrahí E, Cucchiari D, Ventura-Aguiar P, De Sousa-Amorim E, Revuelta I, Cofan F, Solé M, García-Herrera A, Diekmann F, Poch E, Quintana LF.

Case Rep Transplant. 2019 Mar 18;2019:7438254. doi: 10.1155/2019/7438254. eCollection 2019.

4.

Pyomyositis in a Patient with IgA Nephropathy and Kidney Transplant.

Xipell M, Ventura-Aguiar P, Revuelta I, Bodro M, Diekmann F.

Case Rep Transplant. 2019 Jan 28;2019:7305683. doi: 10.1155/2019/7305683. eCollection 2019.

5.

Predictive and Comparative Study Between Clinic Consensus Document for Pancreas Acceptance and Predictive Value of Preprocurement Pancreas Allocation Suitability Score (P-PASS).

Rodríguez-Villar C, Paredes D, Roque R, Gelpi R, Ruíz A, Ventura-Aguiar P, Ferrer J, Diekmann F, Adalia R.

Transplant Proc. 2019 Mar;51(2):365-368. doi: 10.1016/j.transproceed.2018.10.001. Epub 2018 Oct 28.

PMID:
30879542
6.

Outcomes From Brain Death Donors With Previous Cardiac Arrest Accepted for Pancreas Transplantation: A Single-center Retrospective Analysis.

Ventura-Aguiar P, Ferrer J, Paredes D, Rodriguez-Villar C, Ruiz A, Fuster J, Fondevila C, Garcia-Valdecasas JC, Esmatjes E, Adália R, Oppenheimer F, Campistol JM, Diekmann F, Ricart MJ.

Ann Surg. 2019 Feb 8. doi: 10.1097/SLA.0000000000003218. [Epub ahead of print]

PMID:
30829695
7.

Do we still need to demonstrate the survival benefit of pancreas transplantation?

Ventura-Aguiar P, Ferrer J, Rovira J, Diekmann F.

Am J Transplant. 2019 Apr;19(4):1241-1242. doi: 10.1111/ajt.15180. Epub 2018 Dec 4. No abstract available.

PMID:
30417964
8.

Modularity and Blended Methodology on Master Education for Donation and Transplantation.

Coll Pérez A, Ballesté Delpierre C, Valero Castell R, Paredes Zapata D, Torregrosa Prats V, Diekmann F, Navarro A, Adalia R, Colmenero J, Manyalich Vidal M.

Transplant Proc. 2018 Oct;50(8):2317-2319. doi: 10.1016/j.transproceed.2018.05.009. Epub 2018 May 16.

PMID:
30316349
9.

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection.

Piñeiro GJ, De Sousa-Amorim E, Solé M, Ríos J, Lozano M, Cofán F, Ventura-Aguiar P, Cucchiari D, Revuelta I, Cid J, Palou E, Campistol JM, Oppenheimer F, Rovira J, Diekmann F.

BMC Nephrol. 2018 Oct 11;19(1):261. doi: 10.1186/s12882-018-1057-4.

10.

Assessment of donor satisfaction as an essential part of living donor kidney transplantation: an eleven-year retrospective study.

Menjivar A, Torres X, Paredes D, Avinyo N, Peri JM, De Sousa-Amorim E, Oppenheimer F, Manyalich M, Diekmann F, Revuelta I.

Transpl Int. 2018 Dec;31(12):1332-1344. doi: 10.1111/tri.13334. Epub 2018 Sep 10.

PMID:
30144365
11.

Hepatitis C viremia as a risk factor for opportunistic infections in kidney transplant recipients.

Bodro M, Londoño MC, Esforzado N, Sanclemente G, Linares L, Solano MF, Cofan F, Marcos MA, Diekmann F, Moreno A.

Clin Transplant. 2018 Oct;32(10):e13382. doi: 10.1111/ctr.13382. Epub 2018 Sep 27.

PMID:
30129986
12.

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C, Viebahn R, Fehrman-Ekholm I, Masnou N, Berenguer M, Potena L, Wennberg L, O'Grady J, Epailly E, Diekmann F, Binet I, Schwenger V, Kuypers D, Guthoff M.

Transplantation. 2018 Sep;102(9S Suppl 1):S1-S14. doi: 10.1097/TP.0000000000002316. No abstract available.

PMID:
30113932
13.

The development of a predictive model of graft function in uncontrolled donors after circulatory death: validity of a pulsatile renal preservation machine cut-off value for kidney acceptance.

Gelpi R, Paredes D, Rodríguez-Villar C, Roque R, Ruiz A, Adalia R, Peri-Cusí L, Sole M, Oppenheimer F, Diekmann F.

Nephrol Dial Transplant. 2019 Mar 1;34(3):531-538. doi: 10.1093/ndt/gfy241.

PMID:
30085267
14.

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.

Meneghini M, Melilli E, Martorell J, Revuelta I, Rigol-Monzó E, Manonelles A, Montero N, Cucchiari D, Diekmann F, Cruzado JM, Gil-Vernet S, Grinyó JM, Bestard O.

Kidney Int Rep. 2018 Mar 30;3(4):926-938. doi: 10.1016/j.ekir.2018.03.015. eCollection 2018 Jul. Erratum in: Kidney Int Rep. 2019 Mar 04;4(4):634.

15.

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF.

Clin Kidney J. 2018 Jun;11(3):422-428. doi: 10.1093/ckj/sfx128. Epub 2017 Nov 22.

16.

Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications.

Schinstock CA, Sapir-Pichhadze R, Naesens M, Batal I, Bagnasco S, Bow L, Campbell P, Clahsen-van Groningen MC, Cooper M, Cozzi E, Dadhania D, Diekmann F, Budde K, Lower F, Orandi BJ, Rowshani AT, Cornell L, Kraus E.

Am J Transplant. 2019 Jan;19(1):123-131. doi: 10.1111/ajt.14979. Epub 2018 Jul 19.

PMID:
29935060
17.

Pancreas outcomes between living and deceased kidney donor in pancreas after kidney transplantation patients.

Ventura-Aguiar P, Ferrer J, Revuelta I, Paredes D, de Sousa-Amorim E, Rovira J, Esmatjes E, Garcia-Valdecasas JC, Campistol JM, Oppenheimer F, Diekmann F, Ricart MJ.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2052-2059. doi: 10.1093/ndt/gfy133.

PMID:
29893956
18.

Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.

Cristelli MP, Trullàs JC, Cofán F, Rico N, Manzardo C, Ambrosioni J, Bedini JL, Moreno A, Diekmann F, Miro JM; CKD-H. Clinical Investigators.

Braz J Infect Dis. 2018 May - Jun;22(3):193-201. doi: 10.1016/j.bjid.2018.05.001. Epub 2018 May 18.

19.

Ultrafast Doublon Dynamics in Photoexcited 1T-TaS_{2}.

Ligges M, Avigo I, Golež D, Strand HUR, Beyazit Y, Hanff K, Diekmann F, Stojchevska L, Kalläne M, Zhou P, Rossnagel K, Eckstein M, Werner P, Bovensiepen U.

Phys Rev Lett. 2018 Apr 20;120(16):166401. doi: 10.1103/PhysRevLett.120.166401. Erratum in: Phys Rev Lett. 2019 Apr 19;122(15):159901.

PMID:
29756943
20.

Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies.

Gelpi R, Rodríguez-Villar C, Paredes D, Roque R, Ruiz A, Adalia R, de Sousa E, Revuelta I, Sole M, Martinez M, Navarro M, Lens S, Oppenheimer F, Diekmann F.

Transpl Int. 2018 Aug;31(8):938-939. doi: 10.1111/tri.13270. Epub 2018 May 11. No abstract available.

PMID:
29687492
21.

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F.

Transplantation. 2018 Jul;102(7):1075-1084. doi: 10.1097/TP.0000000000002204.

PMID:
29620612
22.

Light-Induced Spin Crossover in an Fe(II) Low-Spin Complex Enabled by Surface Adsorption.

Rohlf S, Gruber M, Flöser BM, Grunwald J, Jarausch S, Diekmann F, Kalläne M, Jasper-Toennies T, Buchholz A, Plass W, Berndt R, Tuczek F, Rossnagel K.

J Phys Chem Lett. 2018 Apr 5;9(7):1491-1496. doi: 10.1021/acs.jpclett.8b00338. Epub 2018 Mar 9.

PMID:
29510617
23.

Association of Brain-Dead Donors' Terminal Inflammation With Delayed Graft Function in Kidney Transplant Recipients.

Cucchiari D, Rovira J, Paredes D, Ventura-Aguiar P, Sanchez-Escuredo A, Solé M, Adalia R, Oppenheimer F, Diekmann F, Revuelta I.

Transplant Proc. 2017 Dec;49(10):2260-2264. doi: 10.1016/j.transproceed.2017.10.003.

PMID:
29198657
24.

The effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes.

Jager KJ, Stel VS, Branger P, Guijt M, Busic M, Dragovic M, Diekmann F, Manyalich M, Di Ciaccio P, Nanni Costa A, Collett D, Mumford L, Haase B, Hemke A, Deme O, Mihály S, Murphy M, Couchoud C, Massy Z, Lingemann M, Rahmel A.

Nephrol Dial Transplant. 2018 Apr 1;33(4):560-562. doi: 10.1093/ndt/gfx082.

PMID:
29106604
25.

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities.

Pascual J, Diekmann F, Fernández-Rivera C, Gómez-Marqués G, Gutiérrez-Dalmau A, Pérez-Sáez MJ, Sancho-Calabuig A, Oppenheimer F.

Nefrologia. 2017 May - Jun;37(3):253-266. doi: 10.1016/j.nefro.2016.11.007. Epub 2017 May 24. English, Spanish.

26.

Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3-year retrospective cohort study.

Cristelli MP, Cofán F, Tedesco-Silva H, Trullàs JC, Santos DWCL, Manzardo C, Agüero F, Moreno A, Oppenheimer F, Diekmann F, Medina-Pestana JO, Miro JM; Sao Paulo-Barcelona Renal Transplant in HIV Investigators.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12724. Epub 2017 Jun 26.

PMID:
28508573
27.

Histopathological evaluation of pretransplant donor biopsies in expanded criteria donors with high kidney donor profile index: a retrospective observational cohort study.

Sánchez-Escuredo A, Sagasta A, Revuelta I, Rodas LM, Paredes D, Musquera M, Diekmann F, Campistol JM, Solé M, Oppenheimer F.

Transpl Int. 2017 Oct;30(10):975-986. doi: 10.1111/tri.12966. Epub 2017 Jun 2.

28.

Death of recipients after kidney living donation triples donors' risk of dropping out from follow-up: a retrospective study.

Torres X, Comas J, Arcos E, Tort J, Diekmann F.

Transpl Int. 2017 Jun;30(6):603-610. doi: 10.1111/tri.12946. Epub 2017 Apr 22.

29.

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.

Sentís A, Diekmann F, Llobell A, de Moner N, Espinosa G, Yagüe J, Campistol JM, Mirapeix E, Juan M.

Immunobiology. 2017 Apr;222(4):620-630. doi: 10.1016/j.imbio.2016.11.011. Epub 2016 Nov 17.

PMID:
27986304
30.

Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.

Martina MN, Ramirez Bajo MJ, Bañon-Maneus E, Moya Rull D, Hierro-Garcia N, Revuelta I, Campistol JM, Rovira J, Diekmann F.

Transplant Proc. 2016 Nov;48(9):3046-3052. doi: 10.1016/j.transproceed.2016.07.052.

PMID:
27932144
31.

Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.

Fallenberg EM, Schmitzberger FF, Amer H, Ingold-Heppner B, Balleyguier C, Diekmann F, Engelken F, Mann RM, Renz DM, Bick U, Hamm B, Dromain C.

Eur Radiol. 2017 Jul;27(7):2752-2764. doi: 10.1007/s00330-016-4650-6. Epub 2016 Nov 28.

PMID:
27896471
32.

Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.

Cervera C, Cofan F, Hernandez C, Soy D, Marcos MA, Sanclemente G, Bodro M, Moreno A, Diekmann F, Campistol JM, Oppenheimer F.

Transpl Int. 2016 Nov;29(11):1216-1225. doi: 10.1111/tri.12848. Epub 2016 Sep 26.

33.

Failed ABO incompatible high titers kidney transplant using bortezomib. Case report.

De Sousa-Amorim E, Revuelta I, Diekmann F, Cid J, Lozano M, Oppenheimer F.

Nefrologia. 2016 Nov - Dec;36(6):701-704. doi: 10.1016/j.nefro.2016.05.022. Epub 2016 Aug 25. English, Spanish. No abstract available.

34.

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

Tedesco-Silva H, Peddi VR, Sánchez-Fructuoso A, Marder BA, Russ GR, Diekmann F, Flynn A, Hahn CM, Li H, Tortorici MA, Schulman SL.

Transplant Direct. 2016 Mar 3;2(4):e69. doi: 10.1097/TXD.0000000000000579. eCollection 2016 Apr.

35.

mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Moya-Rull D, Ventura-Aguiar P, Hierro-Garcia N, Lazo-Rodriguez M, Revuelta I, Torres A, Oppenheimer F, Campistol JM, Diekmann F.

Transplant Direct. 2016 Jan 22;2(2):e65. doi: 10.1097/TXD.0000000000000576. eCollection 2016 Feb.

36.

Therapeutic application of extracellular vesicles in acute and chronic renal injury.

Rovira J, Diekmann F, Campistol JM, Ramírez-Bajo MJ.

Nefrologia. 2017 Mar - Apr;37(2):126-137. doi: 10.1016/j.nefro.2016.04.006. Epub 2016 Jul 25. Review. English, Spanish.

37.

Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.

Hernández-Sierra A, Rovira J, Petit A, Moya-Rull D, Mazuecos MA, Sánchez-Fructuoso AI, Errasti P, Idoate MÁ, Cruzado JM, Vidal A, Diekmann F, Oppenheimer F, Campistol JM, Revuelta I.

Transpl Int. 2016 Sep;29(9):1008-16. doi: 10.1111/tri.12800. Epub 2016 Jul 7.

38.

Borderline rejection in ABO-incompatible kidney transplantation.

Sánchez-Escuredo A, Oppenheimer F, Solé M, Revuelta I, Cid J, Lozano M, Blasco M, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Paredes D, Musquera M, Ercilla G, Campistol JM, Diekmann F.

Clin Transplant. 2016 Aug;30(8):872-9. doi: 10.1111/ctr.12759. Epub 2016 Jul 28.

PMID:
27146439
39.

An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.

Sánchez-Escuredo A, Diekmann F, Revuelta I, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Peri L, Ruiz Á, Campistol JM, Oppenheimer F.

Transpl Int. 2016 Mar;29(3):362-8. doi: 10.1111/tri.12732.

40.

Safety of mTOR inhibitors in adult solid organ transplantation.

Ventura-Aguiar P, Campistol JM, Diekmann F.

Expert Opin Drug Saf. 2016;15(3):303-19. doi: 10.1517/14740338.2016.1132698. Epub 2016 Jan 28. Review.

PMID:
26667069
41.

Pre-Emptive Retransplantation in Patients With Chronic Kidney Graft Failure.

Florit EA, Bennis S, Rodriguez E, Revuelta I, De Sousa E, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Campistol JM, Oppenheimer F, Diekmann F.

Transplant Proc. 2015 Oct;47(8):2351-3. doi: 10.1016/j.transproceed.2015.09.003.

PMID:
26518924
42.

Living Donor Transplantation: Long-Term Evolution Related to Age Matching.

Florit EA, Diekmann F, Budde K, Glander P, Liefeldt L, Nistal J, Oppenheimer F, Campistol JM, Brakemeier S.

Transplant Proc. 2015 Oct;47(8):2346-50. doi: 10.1016/j.transproceed.2015.09.002.

PMID:
26518923
43.

Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers.

Gelpi R, Cid J, Lozano M, Revuelta I, Sanchez-Escuredo A, Blasco M, de Souza E, Esforzado N, Torregrosa JV, Cofán F, Ricart MJ, Campistol JM, Oppenheimer F, Diekmann F.

Transplant Proc. 2015 Oct;47(8):2340-3. doi: 10.1016/j.transproceed.2015.08.021.

PMID:
26518921
44.

Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.

De Sousa-Amorim E, Revuelta I, Blasco M, Diekmann F, Cid J, Lozano M, Sánchez-Escuredo A, Martorell J, Palou E, Campistol JM, Oppenheimer F.

Transplant Proc. 2015 Oct;47(8):2332-5. doi: 10.1016/j.transproceed.2015.09.025.

PMID:
26518919
45.

Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.

De Sousa-Amorim E, Revuelta I, Diekmann F, Cofan F, Lozano M, Cid J, Palou E, Sole M, Campistol JM, Oppenheimer F.

Nephrology (Carlton). 2016 Aug;21(8):700-4. doi: 10.1111/nep.12659.

PMID:
26492594
46.

High Incidence of Paralytic Ileus After Bortezomib Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: Report of 2 Cases.

De Sousa-Amorim E, Revuelta I, Diekmann F, Cofan F, Cid J, Lozano M, Campistol JM, Oppenheimer F.

Transplantation. 2015 Nov;99(11):e170-1. doi: 10.1097/TP.0000000000000930. No abstract available.

PMID:
26492053
47.

Kidney transplant from a living monozygotic twin donor with no maintenance immunosuppression.

Sánchez-Escuredo A, Barajas A, Revuelta I, Blasco M, Cofan F, Esforzado N, Ricart MJ, Torregrosa V, Campistol JM, Oppenheimer F, Diekmann F.

Nefrologia. 2015;35(4):358-62. doi: 10.1016/j.nefro.2015.06.006. Epub 2015 Jul 8. English, Spanish.

48.

Immunosuppressive minimization with mTOR inhibitors and belatacept.

Diekmann F.

Transpl Int. 2015 Aug;28(8):921-7. doi: 10.1111/tri.12603. Epub 2015 Jun 8. Review.

49.

A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.

Canha C, Ferreira R, Rovira J, Moya-Rull D, Castells A, Diekmann F, Oppenheimer F, Campistol JM, Revuelta I.

Transpl Int. 2015 Oct;28(10):1240-4. doi: 10.1111/tri.12600. Epub 2015 May 19.

50.

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.

Quintana LF, Blasco M, Seras M, Pérez NS, López-Hoyos M, Villarroel P, Rodrigo E, Viñas O, Ercilla G, Diekmann F, Gómez-Roman JJ, Fernandez-Fresnedo G, Oppenheimer F, Arias M, Campistol JM.

Transplantation. 2015 Aug;99(8):1709-14. doi: 10.1097/TP.0000000000000630.

PMID:
25675198

Supplemental Content

Loading ...
Support Center